Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2545 EUR | +3.88% | +2.41% | +10.65% |
Business Summary
Number of employees: 13
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 10-04-30 | |
Heike Balzer
DFI | Director of Finance/CFO | - | 99-12-31 |
Ewelina Staniuk
IRC | Investor Relations Contact | - | 17-12-31 |
Karen Ophoff
HRO | Human Resources Officer | - | 00-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 53 | 20-06-29 | |
Chairman | 76 | 16-08-31 | |
Susan Coles
BRD | Director/Board Member | 58 | 21-06-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,320,845 | 1,721,941 ( 9.941 %) | 36,007 ( 0.2079 %) | 9.941 % |
Company contact information
Sector
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.65% | 7.79M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- ALTME Stock
- Company TME Pharma N.V.